# Rapamycin (low-dose)

**Category:** pharmaceutical
**Evidence Grade:** B
**Risk Profile:** medium

## Description
Extends lifespan in mice by 10-25%

## Mechanisms of Action
- mTOR inhibition
- Autophagy induction
- Immune modulation

## Dosage
- **Standard:** 5-6mg/week
- **Range:** 1-8mg/week
- **Notes:** Intermittent dosing (weekly or biweekly). Requires medical supervision.

## Key Findings
- Extends lifespan in mice by 10-25%
- PEARL trial: improved immune function in elderly at low doses
- Off-label use growing in longevity community

## Interactions


## Side Effects


## Contraindications
- Immunocompromised
- Active infections
- Upcoming surgery

## Sources


## Suppliers


---
*Last updated: 2026-02-04T08:33:44.502Z*
